Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Endobronchial brachytherapy].

M Taulelle1, B Chauvet, P Vincent

  • 1VALMEDICA, Ville Active, Nîmes.

Revue Des Maladies Respiratoires
|July 18, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence of burnout, depression and job satisfaction among French senior and resident radiation oncologists.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2018
Same author

[Spinal stereotactic body radiotherapy: French assessment in 2016].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2017
Same author

[Interest of positioning control in onboard imaging and its delegation to the therapists].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2016
Same author

[Respiratory synchronization and breast radiotherapy].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2016
Same author

[Image-guided radiotherapy].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2016
Same author

[Radiotherapy of breast cancer].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2016
Same journal

[French version of the guidelines for connective tissue disease-associated ILD].

Revue des maladies respiratoires·2026
Same journal

[Pulmonary expression of an asymptomatic lysosomal storage disorder].

Revue des maladies respiratoires·2026
Same journal

[Factors associated with FEV1 evolution in cystic fibrosis patients treated by CFTR modulator tritherapy].

Revue des maladies respiratoires·2026
Same journal

[Subacute pulmonary coccidioidomycosis: A differential diagnosis of lung cancer].

Revue des maladies respiratoires·2026
Same journal

[Relevance of the ACT score in severe asthma with obesity: A pilot study].

Revue des maladies respiratoires·2026
Same journal

[Automated analysis of mandibular movements for the screening of obstructive sleep apnea].

Revue des maladies respiratoires·2026
See all related articles

Endobronchial brachytherapy offers high-dose, short-duration treatment for symptomatic bronchial obstruction, achieving 80% response rates. Further research is needed to optimize protocols and minimize complications for broader integration into bronchial cancer treatment.

Area of Science:

  • Oncology
  • Radiation Oncology
  • Pulmonology

Context:

  • Miniaturization of radioactive sources enables fiberoptic delivery of endobronchial brachytherapy.
  • This technique is used with laser therapy for symptomatic proximal bronchial obstruction.

Purpose:

  • To evaluate the efficacy of endobronchial brachytherapy in palliative and potentially curative settings for bronchial cancer.
  • To investigate its role in augmenting local control when used with conventional treatments.

Summary:

  • Endobronchial brachytherapy provides high-dose, short-duration treatment, achieving approximately 80% response rates in palliative cases.
  • It shows efficacy alone for small tumors unsuitable for conventional therapy.
  • Ongoing studies explore its combination with conventional treatments to improve local control.

Related Experiment Videos

Impact:

  • Addresses the need for effective local treatment options in bronchial cancer.
  • Highlights the potential for improved patient outcomes through optimized brachytherapy protocols.
  • Identifies key challenges, including dose fractionation and limiting secondary complications, for future research and clinical integration.